BFRI
Price
$0.88
Change
+$0.03 (+3.53%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
9.08M
HNSPF
Price
$4.58
Change
-$0.62 (-11.92%)
Updated
Aug 25 closing price
Capitalization
27.25B
Interact to see
Advertisement

BFRI vs HNSPF

Header iconBFRI vs HNSPF Comparison
Open Charts BFRI vs HNSPFBanner chart's image
Biofrontera
Price$0.88
Change+$0.03 (+3.53%)
Volume$200
Capitalization9.08M
Hansoh Pharmaceutical Group
Price$4.58
Change-$0.62 (-11.92%)
Volume$800
Capitalization27.25B
BFRI vs HNSPF Comparison Chart in %
Loading...
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BFRI vs. HNSPF commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFRI is a Hold and HNSPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (BFRI: $0.85 vs. HNSPF: $4.58)
Brand notoriety: BFRI and HNSPF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BFRI: 23% vs. HNSPF: 83%
Market capitalization -- BFRI: $9.08M vs. HNSPF: $27.25B
BFRI [@Pharmaceuticals: Generic] is valued at $9.08M. HNSPF’s [@Pharmaceuticals: Generic] market capitalization is $27.25B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BFRI’s FA Score shows that 0 FA rating(s) are green whileHNSPF’s FA Score has 1 green FA rating(s).

  • BFRI’s FA Score: 0 green, 5 red.
  • HNSPF’s FA Score: 1 green, 4 red.
According to our system of comparison, HNSPF is a better buy in the long-term than BFRI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BFRI’s TA Score shows that 3 TA indicator(s) are bullish while HNSPF’s TA Score has 4 bullish TA indicator(s).

  • BFRI’s TA Score: 3 bullish, 6 bearish.
  • HNSPF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, HNSPF is a better buy in the short-term than BFRI.

Price Growth

BFRI (@Pharmaceuticals: Generic) experienced а -2.76% price change this week, while HNSPF (@Pharmaceuticals: Generic) price change was -11.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.25%. For the same industry, the average monthly price growth was +68.20%, and the average quarterly price growth was +81.63%.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HNSPF($27.3B) has a higher market cap than BFRI($9.08M). HNSPF has higher P/E ratio than BFRI: HNSPF (40.96) vs BFRI (0.89). HNSPF YTD gains are higher at: 114.701 vs. BFRI (-21.881).
BFRIHNSPFBFRI / HNSPF
Capitalization9.08M27.3B0%
EBITDA-15.28MN/A-
Gain YTD-21.881114.701-19%
P/E Ratio0.8940.962%
Revenue39.2MN/A-
Total Cash7.25MN/A-
Total Debt5MN/A-
TECHNICAL ANALYSIS
Technical Analysis
BFRIHNSPF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
25%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
46%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
18%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 11 days ago
90%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
50%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CARV1.710.02
+1.01%
Carver Bancorp
ADV1.84N/A
N/A
Advantage Solutions
SHMD2.63-0.01
-0.38%
SCHMID GROUP N.V.
CWT46.87-0.28
-0.59%
California Water Service
GEN30.21-0.53
-1.72%
Gen Digital

BFRI and

Correlation & Price change

A.I.dvisor tells us that BFRI and ACET have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFRI and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
-0.99%
ACET - BFRI
25%
Poorly correlated
+0.40%
DVAX - BFRI
23%
Poorly correlated
+0.10%
HCM - BFRI
23%
Poorly correlated
-0.87%
LNTH - BFRI
23%
Poorly correlated
-2.36%
EVO - BFRI
23%
Poorly correlated
+0.57%
More

HNSPF and

Correlation & Price change

A.I.dvisor tells us that HNSPF and RMTI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HNSPF and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
RMTI - HNSPF
24%
Poorly correlated
+22.45%
AYURF - HNSPF
11%
Poorly correlated
N/A
AKAN - HNSPF
8%
Poorly correlated
+2.81%
IXHL - HNSPF
5%
Poorly correlated
-7.80%
BFRI - HNSPF
4%
Poorly correlated
-0.99%
More